We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SUNC:NYSESunocoCorp LLC Analysis

Data as of 2026-06-08 - not real-time

$66.38

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

SunocoCorp LLC (SUNC) is trading at $66.38, comfortably above its immediate support of $65.31 but still below the 20‑day SMA of 68.7 and the 50‑day SMA of 65.35, indicating a modest bullish bias. The RSI of 46.5 suggests the stock is neither overbought nor oversold, while the MACD histogram remains negative, signaling short‑term bearish momentum despite the overall bullish trend direction. Valuation metrics are compelling: a trailing P/E of 7.38 versus an industry average of 22.44, a price‑to‑book of 1.32, and an implied upside of roughly 13.5% based on analyst targets. The dividend yield stands out at 5.92%, but a payout ratio of zero and zero free cash flow raise questions about long‑term sustainability. On the balance sheet, total debt of $15.4 B dwarfs cash of $0.718 B, resulting in a debt‑to‑equity ratio of 185, while ROE and ROA are both zero, reflecting limited profitability. Volatility is elevated at 28.3% over the past 30 days, beta is slightly negative at -0.20, and trading volume is on a decreasing trend, all of which add layers of risk to the otherwise attractive valuation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bullish SMA alignment
  • Negative MACD histogram indicating short‑term pressure
  • High dividend yield but uncertain sustainability

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount to peers (low P/E, low P/B)
  • Analyst target price suggests ~13% upside
  • Stable midstream cash flow despite high leverage

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated debt‑to‑equity ratio and zero free cash flow
  • Potential regulatory and environmental headwinds in the energy sector
  • Dividend yield attractive but may be at risk if cash generation does not improve

Key Metrics & Analysis

Financial Health

Revenue Growth106.40%
Profit Margin1.19%
P/E Ratio7.4
Debt/Equity185.46
P/B Ratio1.3
Op. Cash Flow$1.5B
Industry P/E22.4

Technical Analysis

TrendBullish
RSI46.5
Support$65.31
Resistance$73.24
MA 20$68.71
MA 50$65.35
MA 200$57.94
MACDBearish
VolumeDecreasing
Fear & Greed Index88.45

Valuation

Fair Value$446.05
Target Price$75.33
Upside/Downside13.49%
GradeUndervalued
TypeValue
Dividend Yield5.92%

Risk Assessment

Beta-0.20
Volatility28.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.